Obesity is a growing global health concern, often leading to serious conditions such as hypertension, type 2 diabetes, and cardiovascular diseases. The imbalance between energy intake and metabolism is a primary cause of obesity.

At the recently concluded 10th Intestinal Microbiome and Health Symposium, Dr. JianGuo Zhu from Wecare Probiotics Institute delivered a compelling keynote speech titled "Screening and Process Optimization of Industrialized Functional Probiotic Strains." The symposium, held in Shanghai from December 20-21, brought together leading experts, researchers, and industry professionals to discuss the latest advancements and future trends in intestinal microbiome research.

This invention introduces the use of Lactobacillus acidophilus LA05 in preparing products designed to reduce blood uric acid levels.

the Wecare Probiotics Research Institute has made a groundbreaking discovery regarding the benefits of Weizmannia coagulans BC99 in improving human strength, facilitating protein digestion, and increasing skeletal muscle content. The clinical research results, which have been published in the prestigious medical journal Nutrients, offer a novel solution for athletes and the elderly population to enhance their athletic performance and nutritional intake through the use of probiotics.

Wecare Probiotics Co., Ltd., a leading national high-tech enterprise in the field of probiotics, is pleased to share new insights from a recent meta-analysis conducted by Chinese researchers, which highlights the effectiveness of probiotic and synbiotic supplementation in improving bowel function in adults suffering from constipation.

Recent research has shed light on the significant role gut microbiota plays in the recovery of liver function post-surgery in patients with liver cancer, particularly hepatocellular carcinoma—the most common type of primary liver cancer and the third leading cause of cancer death.